Načítá se...
Engineering T cells for immunotherapy of primary human hepatocellular carcinoma
Liver cancers, majority of which are primary hepatocellular carcinoma (HCC), continue to be on the rise in the world. Furthermore, due to the lack of effective treatments, liver cancer ranks the 4(th) most common cause of male cancer deaths. Novel therapies are urgently needed. Over last few years,...
Uloženo v:
| Vydáno v: | J Genet Genomics |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7093251/ https://ncbi.nlm.nih.gov/pubmed/32089500 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jgg.2020.01.002 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|